Pharmacokinetic behavior of huperzine A in plasma and cerebrospinal fluid after intranasal administration in rats
โ Scribed by Qiao Wang; Guoshen Chen
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 87 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0142-2782
- DOI
- 10.1002/bdd.686
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
The aim of this study was to investigate the pharmacokinetic behavior of huperzine A (Hup A) in plasma and cerebrospinal fluid (CSF) after intranasal administration (0.5โmg/kg) in male SpragueโDawley rats. A pharmacokinetic study of intravenous Hup A (0.5โmg/kg) was also performed. The concentrations of Hup A in the biological samples were measured by high performance liquid chromatographyโmass spectrometry. Blood samples were taken from the tail vein and CSF was sampled by cisternal puncture using a stereotaxic frame. The contribution of the olfactory pathway to the uptake of Hup A into CSF was determined by comparing the AUC~CSF~/AUC~plasma~ ratios after intranasal and intravenous administration. The AUC ratios of intranasal to intravenous administration in CSF and plasma were 104% and 118%, respectively. No significant difference was observed between the AUC~CSF~/AUC~plasma~ ratios of Hup A after intranasal administration (20%) and after intravenous infusion (23%). This indicated that approximately 20% of the Hup A level in plasma reached the CSF after both nasal and intravenous administration, and that no direct transport of Hup A from nose to CSF was found in rats. Copyright ยฉ 2009 John Wiley & Sons, Ltd.
๐ SIMILAR VOLUMES
Verapamil is a chiral calcium channel blocking drug which is useful clinically as the racemate in treating hypertension and arrhythmia. The published pharmacokinetic data for verapamil enantiomers in the rat model are limited. Utilizing a stereospeciยฎc highperformance liquid chromatographic (HPLC) a